Generalized principles of stochasticity can be used to control dynamic heterogeneity

Physical Biology

Volumn 9, Issue 6, 2012, Pages

  Liao, David ^a   Estévez Salmerón, Luis ^a   Tlsty, Thea D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROTEOME;

ANIMAL; ANIMAL BEHAVIOR; ANT; ARTICLE; BIOFILM; BIOLOGICAL MODEL; CRYPTOCOCCUS NEOFORMANS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; METASTASIS; NEOPLASM; ONCOGENE; PATHOLOGY; PHENOTYPE; PHYSIOLOGY; STATISTICS;

ANIMALS; ANTS; BEHAVIOR, ANIMAL; BIOFILMS; CRYPTOCOCCUS NEOFORMANS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NEOPLASMS; ONCOGENES; PHENOTYPE; PROTEOME; RECEPTOR, ERBB-2; STOCHASTIC PROCESSES;

EID: 84871242000     PISSN: 14783967     EISSN: 14783975     Source Type: Journal    
DOI: 10.1088/1478-3975/9/6/065006     Document Type: Article

References (46)

1. Liao D, Estévez-Salmerón L and Tlsty T D 2012 Conceptualizing a tool to optimize therapy based on dynamic heterogeneity Phys. Biol. 9 065005
2. Kamen B A, Rubin E, Aisner J and Glatstein E 2000 High-time chemotherapy or high time for low dose J. Clin. Oncol. 18 2935-7 (available at http://jco.ascopubs.org/content/18/16/2935.long)
3. Sigal A, Milo R, Cohen A, Geva-Zatorsky N, Klein Y, Liron Y, Rosenfeld N, Danon T, Perzov N and Alon U 2006 Variability and memory of protein levels in human cells Nature 444 643-6
4. Huh D and Paulsson J 2011 Non-genetic heterogeneity from stochastic partitioning at cell division Nature Genet. 43 95-100
5. Kaufman R J, Brown P C and Schimke R T 1981 Loss and stabilization of amplified dihydrofolate reductase genes in mouse sarcoma S-180 cell lines Mol. Cell. Biol. 1 1084-93 (available at http://mcb.asm.org/content/1/12/1084.long)
6. Çaǧatay T, Turcotte M, Elowitz M B, Garcia-Ojalvo J and Süel G M 2009 Architecture-dependent noise discriminates functionally analogous differentiation circuits Cell 139 512-22
7. Spudich J L and Koshland D E Jr 1976 Non-genetic individuality: chance in the single cell Nature 262 467-71
8. Chang H H, Hemberg M, Barahona M, Ingber D E and Huang S 2008 Transcriptome-wide noise controls lineage choice in mammalian progenitor cells Nature 453 544-7
9. Iliopoulos D, Hirsch H A, Wang G and Struhl K 2011 Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion Proc. Natl Acad. Sci. USA 108 1397-402
10. Gupta P B, Fillmore C M, Jiang G, Shapira S D, Tao K, Kuperwasser C and Lander E S 2011 Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells Cell 146 633-44
11. Johnston R N, Beverley S M and Schimke R T 1983 Rapid spontaneous dihydrofolate reductase gene amplification shown by fluorescence-activated cell sorting Proc. Natl Acad. Sci. USA 80 3711-5
12. Kimmel M and Axelrod D E 1990 Mathematical models of gene amplification with applications to cellular drug resistance and tumorigenicity Genetics 125 633-44 (available at http://www.genetics.org/content/125/3/633.long)
13. Foo J and Michor F 2009 Evolution of resistance to targeted anti-cancer therapies during continuous and pulsed administration strategies PLoS Comput. Biol. 5 e1000557
14. Silva A S and Gatenby R A 2010 A theoretical quantitative model for evolution of cancer chemotherapy resistance Biol. Direct 5 1-17
15. Rath H, Tlsty T and Schimke R T 1984 Rapid emergence of methotrexate resistance in cultured mouse cells Cancer Res. 44 3303-6 (available at http://cancerres.aacrjournals.org/content/44/8/3303.short)
16. Martinez L R, Ibom D C, Casadevall A and Fries B C 2008 Characterization of phenotypic switching in Cryptococcus neoformans biofilms Mycopathologia 166 175-80
17. Lambert G, Estévez-Salmeron L, Oh S, Liao D, Emerson B M, Tlsty T D and Austin R H 2011 An analogy between the evolution of drug resistance in bacterial communities and malignant tissues Nature Rev. Cancer 11 375-82
18. Davies P C W and Lineweaver C H 2011 Cancer tumors as Metazoa 1.0: tapping genes of ancient ancestors Phys. Biol. 8 015001
19. Weiss L 1983 Random and nonrandom processes in metastasis, and metastatic inefficiency Invasion Metastasis 3 193-207 (available at http://www.ncbi.nlm. nih.gov/pubmed?term= Weiss%201983%20random%20nonrandom%20metastasis%20ineficiency)
20. Neito M A and Cano A 2012 The epithelial-mesenchymal transition under control: global programs to regulate epithelial plasticity Semin. Cancer Biol. 22 361-8
21. Dumont N, Wilson M B, Crawford Y G, Reynolds P A, Sigaroudinia M and Tlsty T D 2008 Sustained induction of epithelial to mesenchymal transition activates DNA methylation of genes silenced in basal-like breast cancers Proc. Natl Acad. Sci. USA 105 14867-72
22. Elowitz M B, Levine A J, Siggia E D and Swain P S 2002 Stochastic gene expression in a single cell Science 297 1183-6
23. Maheshri N and O'Shea E K 2007 Living with noisy genes: How cells function reliably with inherent variability in gene expression Annu. Rev. Biophys. Biomol. Struct. 36 413-34
24. Kim M Y, Oskarsson T, Acharyya S, Nguyen D X, Zhang X H F, Norton L and Massague J 2009 Tumor self-seeding by circulating cancer cells Cell 139 1315-26
25. Deakin N O and Turner C E 2011 Distinct roles for paxillin and Hic-5 in regulating breast cancer cell morphology, invasion, and metastasis Mol. Biol. Cell 22 327-41
26. Heyn C et al 2006 In vivo MRI of cancer cell fate at the single-cell level in a mouse model of breast cancer metastasis to the brain Magn. Reson. Med. 56 1001-10
27. Ling V, Chambers A F, Harris J F and Hill R P 1984 Dynamic heterogeneity and metastasis J. Cell. Physiol. 121 99-103
28. Park J W, Neve R M, Szollosi J and Benz C C 2008 Unraveling the biologic and clinical complexities of HER2 Clin. Breast Cancer 8 392-401
29. Dean-Colomb W and Esteva F J 2008 Her2-positive breast cancer: herceptin and beyond Eur. J. Cancer 44 2806-12
30. Zaczek A, Brandt B and Bielawski K P 2005 The diverse signaling network of EGFR, HER2, HER3 and HER4 tyrosine kinase receptors and the consequences for therapeutic approaches Histol. Histopathol. 20 1005-15 (available at http://www.hh.um.es/Abstracts/Vol-20/20-3/20-3-1005.htm)
31. Ménard S, Fortis S, Castiglioni F, Agresti R and Balsari A 2001 HER2 as a prognostic factor in breast cancer Oncology 61 (Suppl. 2) 67-72
32. Savelyeva L and Schwab M 2001 Amplification of oncogenes revisited: from expression profiling to clinical application Cancer Lett. 167 115-23
33. Esteva F J, Hortobagyi G N, Sahin A A, Smith T L, Chin D M, Liang S Y, Pusztai L, Buzdar A U and Bacus S S 2001 Expression of erB/HER receptors, heregulin and p38 in primary breast cancer using quantitative immunohistochemistry Pathol. Oncol. Res. 7 171-7
34. Lupu R, Cardillo M, Cho C, Harris L, Hijazi M, Perez C, Rosenberg K, Yang D and Tang C 1996 The significance of heregulin in breast cancer tumor progression and drug resistance Breast Cancer Res. Treat. 38 57-66
35. Gordon D M 1984 The persistence of role in exterior workers of the harvester ant, Pogonomyrmex badius Psyche 91 251-65
36. Gordon D M 1989 Dynamics of task switching in harvester ants Anim. Behav. 38 194-204
37. Greene M J and Gordon D M 2007 Interaction rate informs harvester ant task decisions Behav. Ecol. 18 451-5
38. Kim S, Goel S and Alexander C M 2011 Differentiation generates paracrine cell pairs that maintain basaloid mouse mammary tumors: proof of concept PLoS One 6 e19310
39. Bendall S C et al 2007 IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro Nature 448 1015-21
40. Fordyce C, Fessenden T, Pickering C, Jung J, Singla V, Berman H and Tlsty T 2010 DNA damage drives an Activin A-dependent induction of Cyclooxygenase-2 in premalignant cells and lesions Cancer Prev. Res. 3 190-201
41. Niepel M, Spencer S L and Sorger P K 2009 Non-genetic cell-to-cell variability and the consequences for pharmacology Curr. Opin. Chem. Biol. 13 556-61
42. Sharma S V, Lee D Y, Li B, Quinlan M P, Takahashi F, Maheswaran S, McDermott U, Azizian N, Zou L and Fischbach M A 2010 A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations Cell 141 69-80
43. Spencer S L, Gaudet S, Albeck J G, Burke J M and Sorger P K 2009 Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis Nature 459 428-32
44. Hanna J, Saha K, Pando B, van Zon J, Lengner C J, Creyghton M P, van Oudenaarden A and Jaenisch R 2009 Direct cell reprogramming is a stochastic process amenable to acceleration Nature 462 595-601
45. Dykxhoorn D M and Lieberman J 2005 The silent revolution: RNA interference as basic biology, research tool, and therapeutic Annu. Rev. Med. 56 401-23
46. Ozbudak E M, Thattai M, Kurtser I, Grossman A D and van Oudenaarden A 2002 Regulation of noise in the expression of a single gene Nature Genet. 31 69-73